IGC Pharma
25 hedge funds and large institutions have $815K invested in IGC Pharma in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.08% less ownership
Funds ownership: 3.67% → 3.59% (-0.08%)
15% less capital invested
Capital invested by funds: $954K → $815K (-$139K)
17% less funds holding
Funds holding: 30 → 25 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$28.8K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$10.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.57K |
| 4 |
Squarepoint
New York
|
+$4.59K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$729 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$20.4K |
| 2 |
HF
HRT Financial
New York
|
-$9K |
| 3 |
DP
Dearborn Partners
Chicago,
Illinois
|
-$7.89K |
| 4 |
Jane Street
New York
|
-$5.63K |
| 5 |
VF
Virtu Financial
New York
|
-$4K |
IGC Hedge Fund Activity: Q1 2025 in Review
25 of the 7,469 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q1 2025, worth a combined $815K — down 15% from $954K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IGC and 1 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, adding an estimated $28.8K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $20.4K sold.
- 25 institutional investors held IGC Pharma (IGC) as of Q1 2025, down from 30 in Q4 2024.
- Funds reported $815K of IGC Pharma stock for Q1 2025, down 15% quarter-over-quarter.
- 1 fund opened new IGC Pharma positions in Q1 2025 and 6 closed out, a net change of -5 holders.
- The largest IGC Pharma buyer in Q1 2025 was Citadel Advisors, an estimated $28.8K added.
- The largest IGC Pharma seller in Q1 2025 was Two Sigma Securities, an estimated $20.4K sold.
Based on aggregated 13F filings for Q1 2025.